Alpha 2.0
Login Register
» Articles » PMID: 20862830

Macrophage Activation Syndrome Induced by Etanercept in a Patient with Systemic Sclerosis

Overview
Journal Isr Med Assoc J
Specialty General Medicine
Date 2010 Sep 25
PMID 20862830
Citations 8
Authors
Gary Sterba
Yonit Sterba
Carlos Stempel
Jack Blank
Evelyn Azor
Leslie Gomez
Affiliations
Soon will be listed here.
Citing Articles

Heterogeneity of macrophage activation syndrome and treatment progression.

Dong Y, Wang T, Wu H Front Immunol. 2024; 15:1389710.

PMID: 38736876 PMC: 11082376. DOI: 10.3389/fimmu.2024.1389710.

Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.

Wise L, Zell M Clin Rheumatol. 2023; 42(11):3159-3166.

PMID: 37322269 PMC: 10587217. DOI: 10.1007/s10067-023-06664-y.

Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort.

Andriessen M, Legger G, Bredius R, van Gijn M, Hak A, Hissink Muller P J Clin Immunol. 2023; 43(7):1581-1596.

PMID: 37277582 PMC: 10499949. DOI: 10.1007/s10875-023-01521-8.

Inflammatory arthritis in systemic sclerosis: What to do?.

Blank R, Nwawka O, Yusov A, Gordon J J Scleroderma Relat Disord. 2022; 4(1):3-16.

PMID: 35382152 PMC: 8922577. DOI: 10.1177/2397198318779532.

Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.

Amigues I, Pearlman A, Patel A, Reid P, Robinson P, Sinha R Expert Rev Clin Immunol. 2020; 16(12):1185-1204.

PMID: 33146561 PMC: 7879704. DOI: 10.1080/1744666X.2021.1847084.